vs

Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and Doximity, Inc. (DOCS). Click either name above to swap in a different company.

ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $185.1M, roughly 1.7× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs 4.3%, a 28.9% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs 9.8%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs 1.2%).

Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

AIN vs DOCS — Head-to-Head

Bigger by revenue
AIN
AIN
1.7× larger
AIN
$321.2M
$185.1M
DOCS
Growing faster (revenue YoY)
AIN
AIN
+2.2% gap
AIN
12.0%
9.8%
DOCS
Higher net margin
DOCS
DOCS
28.9% more per $
DOCS
33.3%
4.3%
AIN
Faster 2-yr revenue CAGR
DOCS
DOCS
Annualised
DOCS
25.2%
1.2%
AIN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
AIN
AIN
DOCS
DOCS
Revenue
$321.2M
$185.1M
Net Profit
$13.9M
$61.6M
Gross Margin
31.1%
89.9%
Operating Margin
9.3%
38.9%
Net Margin
4.3%
33.3%
Revenue YoY
12.0%
9.8%
Net Profit YoY
-21.5%
-18.1%
EPS (diluted)
$0.56
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIN
AIN
DOCS
DOCS
Q4 25
$321.2M
$185.1M
Q3 25
$261.4M
$168.5M
Q2 25
$311.4M
$145.9M
Q1 25
$288.8M
$138.3M
Q4 24
$286.9M
$168.6M
Q3 24
$298.4M
$136.8M
Q2 24
$332.0M
$126.7M
Q1 24
$313.3M
$118.1M
Net Profit
AIN
AIN
DOCS
DOCS
Q4 25
$13.9M
$61.6M
Q3 25
$-97.8M
$62.1M
Q2 25
$9.2M
$53.3M
Q1 25
$17.4M
$62.5M
Q4 24
$17.7M
$75.2M
Q3 24
$18.0M
$44.2M
Q2 24
$24.6M
$41.4M
Q1 24
$27.3M
$40.6M
Gross Margin
AIN
AIN
DOCS
DOCS
Q4 25
31.1%
89.9%
Q3 25
-19.1%
90.3%
Q2 25
31.3%
89.2%
Q1 25
33.4%
89.5%
Q4 24
31.5%
91.6%
Q3 24
30.3%
90.0%
Q2 24
33.9%
89.3%
Q1 24
34.7%
89.4%
Operating Margin
AIN
AIN
DOCS
DOCS
Q4 25
9.3%
38.9%
Q3 25
-44.6%
37.8%
Q2 25
7.2%
37.4%
Q1 25
9.8%
35.2%
Q4 24
8.5%
47.4%
Q3 24
8.4%
38.8%
Q2 24
12.9%
36.4%
Q1 24
12.4%
35.5%
Net Margin
AIN
AIN
DOCS
DOCS
Q4 25
4.3%
33.3%
Q3 25
-37.4%
36.8%
Q2 25
2.9%
36.5%
Q1 25
6.0%
45.2%
Q4 24
6.2%
44.6%
Q3 24
6.0%
32.3%
Q2 24
7.4%
32.7%
Q1 24
8.7%
34.4%
EPS (diluted)
AIN
AIN
DOCS
DOCS
Q4 25
$0.56
$0.31
Q3 25
$-3.37
$0.31
Q2 25
$0.31
$0.27
Q1 25
$0.56
$0.31
Q4 24
$0.57
$0.37
Q3 24
$0.57
$0.22
Q2 24
$0.79
$0.21
Q1 24
$0.87
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIN
AIN
DOCS
DOCS
Cash + ST InvestmentsLiquidity on hand
$112.3M
$64.8M
Total DebtLower is stronger
$455.7M
Stockholders' EquityBook value
$726.2M
$979.3M
Total Assets
$1.7B
$1.2B
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIN
AIN
DOCS
DOCS
Q4 25
$112.3M
$64.8M
Q3 25
$108.3M
$169.2M
Q2 25
$106.7M
$137.3M
Q1 25
$119.4M
$209.6M
Q4 24
$115.3M
$165.3M
Q3 24
$127.2M
$184.2M
Q2 24
$116.4M
$111.4M
Q1 24
$125.4M
$96.8M
Total Debt
AIN
AIN
DOCS
DOCS
Q4 25
$455.7M
Q3 25
$480.6M
Q2 25
$444.7M
Q1 25
$416.4M
Q4 24
$318.5M
Q3 24
$362.2M
Q2 24
$377.1M
Q1 24
$439.1M
Stockholders' Equity
AIN
AIN
DOCS
DOCS
Q4 25
$726.2M
$979.3M
Q3 25
$739.3M
$1.1B
Q2 25
$888.6M
$1.0B
Q1 25
$900.0M
$1.1B
Q4 24
$943.5M
$1.0B
Q3 24
$991.0M
$961.2M
Q2 24
$967.5M
$913.6M
Q1 24
$967.5M
$901.4M
Total Assets
AIN
AIN
DOCS
DOCS
Q4 25
$1.7B
$1.2B
Q3 25
$1.7B
$1.3B
Q2 25
$1.7B
$1.2B
Q1 25
$1.7B
$1.3B
Q4 24
$1.6B
$1.2B
Q3 24
$1.8B
$1.1B
Q2 24
$1.8B
$1.1B
Q1 24
$1.8B
$1.1B
Debt / Equity
AIN
AIN
DOCS
DOCS
Q4 25
0.63×
Q3 25
0.65×
Q2 25
0.50×
Q1 25
0.46×
Q4 24
0.34×
Q3 24
0.37×
Q2 24
0.39×
Q1 24
0.45×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIN
AIN
DOCS
DOCS
Operating Cash FlowLast quarter
$73.7M
$60.9M
Free Cash FlowOCF − Capex
$51.4M
FCF MarginFCF / Revenue
16.0%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
5.31×
0.99×
TTM Free Cash FlowTrailing 4 quarters
$82.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIN
AIN
DOCS
DOCS
Q4 25
$73.7M
$60.9M
Q3 25
$43.9M
$93.9M
Q2 25
$32.7M
$62.1M
Q1 25
$2.1M
$98.5M
Q4 24
$78.5M
$65.2M
Q3 24
$47.0M
$68.3M
Q2 24
$83.4M
$41.2M
Q1 24
$9.6M
$63.9M
Free Cash Flow
AIN
AIN
DOCS
DOCS
Q4 25
$51.4M
Q3 25
$25.9M
Q2 25
$18.8M
Q1 25
$-13.5M
Q4 24
$60.2M
Q3 24
$31.6M
Q2 24
$63.6M
Q1 24
$-17.3M
FCF Margin
AIN
AIN
DOCS
DOCS
Q4 25
16.0%
Q3 25
9.9%
Q2 25
6.0%
Q1 25
-4.7%
Q4 24
21.0%
Q3 24
10.6%
Q2 24
19.2%
Q1 24
-5.5%
Capex Intensity
AIN
AIN
DOCS
DOCS
Q4 25
6.9%
Q3 25
6.9%
Q2 25
4.5%
Q1 25
5.4%
0.0%
Q4 24
6.4%
0.0%
Q3 24
5.2%
0.0%
Q2 24
6.0%
0.0%
Q1 24
8.6%
0.0%
Cash Conversion
AIN
AIN
DOCS
DOCS
Q4 25
5.31×
0.99×
Q3 25
1.51×
Q2 25
3.56×
1.16×
Q1 25
0.12×
1.58×
Q4 24
4.44×
0.87×
Q3 24
2.61×
1.55×
Q2 24
3.39×
1.00×
Q1 24
0.35×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIN
AIN

Transferred At Point In Time$176.5M55%
Engineered Composites Other$99.3M31%
Engineered Composites ASC$44.5M14%
Transferred Over Time$1.0M0%

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

Related Comparisons